ASC Stock Overview
A health and wellness company, manufactures and distributes healthcare products in South Africa.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Ascendis Health Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | R0.71 |
52 Week High | R0.83 |
52 Week Low | R0.63 |
Beta | 0.67 |
11 Month Change | 1.43% |
3 Month Change | -1.39% |
1 Year Change | 4.41% |
33 Year Change | -29.70% |
5 Year Change | -76.09% |
Change since IPO | -93.60% |
Recent News & Updates
Shareholder Returns
ASC | ZA Pharmaceuticals | ZA Market | |
---|---|---|---|
7D | -1.4% | -1.5% | -0.9% |
1Y | 4.4% | 5.5% | 19.0% |
Return vs Industry: ASC underperformed the ZA Pharmaceuticals industry which returned 5.5% over the past year.
Return vs Market: ASC underperformed the ZA Market which returned 19% over the past year.
Price Volatility
ASC volatility | |
---|---|
ASC Average Weekly Movement | 6.5% |
Pharmaceuticals Industry Average Movement | 6.4% |
Market Average Movement | 4.5% |
10% most volatile stocks in ZA Market | 9.5% |
10% least volatile stocks in ZA Market | 2.7% |
Stable Share Price: ASC has not had significant price volatility in the past 3 months compared to the ZA market.
Volatility Over Time: ASC's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 14 | A. Neethling | www.ascendishealth.com |
Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa. It operates through Consumer Health, and Medical Devices segments. The company offers natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Preg, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Solal, and Vitaforce brand names.
Ascendis Health Limited Fundamentals Summary
ASC fundamental statistics | |
---|---|
Market cap | R444.28m |
Earnings (TTM) | R41.57m |
Revenue (TTM) | R1.47b |
10.7x
P/E Ratio0.3x
P/S RatioIs ASC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ASC income statement (TTM) | |
---|---|
Revenue | R1.47b |
Cost of Revenue | R886.86m |
Gross Profit | R585.18m |
Other Expenses | R543.61m |
Earnings | R41.57m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.066 |
Gross Margin | 39.75% |
Net Profit Margin | 2.82% |
Debt/Equity Ratio | 0.8% |
How did ASC perform over the long term?
See historical performance and comparison